Company profile for Psyence

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Psilocybin has dominated the news cycle from the Wall Street Journal to the Financial Times. Public opinion has shifted attitudes toward psychedelics and healing; patients, families, and physicians are demanding new solutions. Governments and regulators are listening and so is the Psyence Group. We are working towards providing safe, legal psilocybin-based solutions. Breaking new ground, Psyence established one of the first l...
Psilocybin has dominated the news cycle from the Wall Street Journal to the Financial Times. Public opinion has shifted attitudes toward psychedelics and healing; patients, families, and physicians are demanding new solutions. Governments and regulators are listening and so is the Psyence Group. We are working towards providing safe, legal psilocybin-based solutions. Breaking new ground, Psyence established one of the first legal and federally licensed commercial natural psilocybin cultivation and production facilities in the world in 2020, in the Kingdom of Lesotho

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
200 Bay Street, Toronto, ON, M5J2J1
Telephone
Telephone
+1-416-477-1708
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

Global ChemShow

Not Confirmed

envelop Contact Supplier

Global ChemShow

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/25/3194192/0/en/Psyence-BioMed-Announces-Groundbreaking-Psilocybin-Longevity-Research-Program.html

GLOBENEWSWIRE
25 Nov 2025

https://www.pharmiweb.com/press-release/2025-11-24/psyence-group-inc-enters-into-amalgamation-agreement-with-goldcoast-resource-corp

PHARMIWEB
24 Nov 2025

https://www.pharmiweb.com/press-release/2025-10-17/psyence-group-inc-announces-rsu-grants

PHARMIWEB
17 Oct 2025

https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/psyence-group-inc.-enters-into-a-letter-of-intent-to-acquire-goldcoas-1064233

ACCESSWIRE
22 Aug 2025

https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/psyence-group-inc.-closes-second-tranche-of-non%e2%80%91brokered-private-plac-1046195

ACCESSWIRE
07 Jul 2025

https://www.globenewswire.com/news-release/2025/06/25/3105471/0/en/PSYENCE-GROUP-INC-Announces-Update-on-Previously-Announced-Non-Brokered-Private-Placement-of-Common-Shares.html

GLOBENEWSWIRE
25 Jun 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty